Population and bayesian pharmacokinetics in oncology
- 31 December 1994
- journal article
- review article
- Published by Elsevier BV in Clinical Oncology
- Vol. 6 (4), 254-260
- https://doi.org/10.1016/s0936-6555(05)80297-3
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile?Cancer Chemotherapy and Pharmacology, 1993
- Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentClinical Pharmacology & Therapeutics, 1992
- Is Dose Normalization to Weight or Body Surface Area Useful in Adults?JNCI Journal of the National Cancer Institute, 1990
- Intravenous Theophylline Therapy: Nomogram GuidelinesAnnals of Internal Medicine, 1977
- Individualization of phenytoin dosage regimensCancer Cell, 1977
- Gentamicin Serum Concentrations: Pharmacokinetic PredictionsAnnals of Internal Medicine, 1976
- SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSYThe Lancet, 1975
- An Improved Method of Digoxin TherapyAnnals of Internal Medicine, 1968
- A mathematical analysis of digitalis kinetics in patients with normal and reduced renal functionMathematical Biosciences, 1967
- Formal theory of drug dosage regimens. IJournal of Theoretical Biology, 1966